{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:50:22Z","timestamp":1769604622878,"version":"3.49.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Paraneoplastic cerebellar degeneration (PCD) is a rare neurodegenerative syndrome associated with antibodies targeting the Purkinje cells of the cerebellum. Most cases of anti-Yo-associated PCD occur in females, with &lt;20 cases reported in males. Herein, we report a male patient with anti-Yo-associated PCD who was treated with plasma exchange and achieved a favorable outcome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 64-year-old man presented with progressive ataxia, gait instability, and dysuria. Electroencephalography, electromyography, brain and spinal neuroimaging, and routine laboratory examinations were all normal. The anti-neuronal antibody Anti-Yo was detected in the serum but not in the cerebrospinal fluid (CSF).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The patient was diagnosed with definite anti-Yo-associated PCD based on the clinical manifestations, anti-Yo was detected in the serum and response to treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>At beginning, the patient was treated with dexamethasone (10\u200amg\/day for 10 days). Then, plasma exchange was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After treated with dexamethasone, no clinical improvement was noted in this patient. In the following month, his condition deteriorated. However, after two courses of plasma exchange, neurological examination showed marked improvement in gait. After four courses of plasma exchange, the patient could walk independently, the Romberg test was negative, and anti-Yo antibodies were undetectable. At the 6-month follow-up, the patients\u2019 symptoms were relieved, and tests for anti-Yo antibodies remained negative.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons subsections:<\/jats:title>\n            <jats:p>Treatment with plasma exchange for anti-Yo-associated male PCD patients without a concomitant tumor are recommend and need more studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021760","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T06:00:29Z","timestamp":1597298429000},"page":"e21760","source":"Crossref","is-referenced-by-count":12,"title":["Plasma exchange for treating anti-Yo-associated paraneoplastic cerebellar degeneration"],"prefix":"10.1097","volume":"99","author":[{"given":"Feng-Qi","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Nephrology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Rong","family":"Shang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Nephrology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/acn3.328","article-title":"Paraneoplastic cerebellar degeneration with anti-Yo antibodies\u2014a review","volume":"3","author":"Venkatraman","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/pon.3270","article-title":"Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review","volume":"22","author":"Key","year":"2013","journal-title":"Psychooncology"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1774-9987.2004.00198.x","article-title":"A case report of plasma exchange therapy in non-paraneoplastic cerebellar ataxia associated with anti-Yo antibody","volume":"8","author":"Meloni","year":"2004","journal-title":"Ther Apher Dial"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/jnnp-2017-316829","article-title":"Purkinje cell cytoplasmic antibody type I (anti-Yo): predictive of gastrointestinal adenocarcinomas in men","volume":"89","author":"Linnoila","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","article-title":"Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients","volume":"42","author":"Peterson","year":"1992","journal-title":"Neurology"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0025-6196(12)62166-1","article-title":"Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies","volume":"65","author":"Hammack","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1212\/WNL.46.5.1486","article-title":"Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of unknown origin","volume":"46","author":"Krakauer","year":"1996","journal-title":"Neurology"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/1531-8249(20010201)49:2<253::AID-ANA47>3.0.CO;2-3","article-title":"Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus","volume":"49","author":"Sutton","year":"2001","journal-title":"Ann Neurol"},{"key":"R10-20230915","first-page":"55","article-title":"Immunomodulatory treatment trial for paraneoplastic neurological disorders","volume":"6","author":"Vernino","year":"2004","journal-title":"Neurooncology"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1744-9987.2007.00546.x","article-title":"A case report of plasmapheresis treatment in a patient with paraneoplastic cerebellar degeneration and high anti-yo antibody titers","volume":"12","author":"Landtblom","year":"2008","journal-title":"Ther Apher Dial"},{"key":"R12-20230915","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-008208","article-title":"Gross cerebellar paraneoplastic neurological disorder in a patient with an occult breast cancer","author":"Poudel","year":"2013","journal-title":"BMJ Case Rep"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"e8468","DOI":"10.1097\/MD.0000000000008468","article-title":"Rehabilitation for a patient with anti-Yo antibody-positive paraneoplastic cerebellar degeneration caused by breast cancer: a case report and literature review","volume":"96","author":"Kato","year":"2017","journal-title":"Medicine"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"e0123446","DOI":"10.1371\/journal.pone.0123446","article-title":"Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers","volume":"10","author":"Greenlee","year":"2015","journal-title":"PLoS One"},{"key":"R15-20230915","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021760","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:14:04Z","timestamp":1694826844000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021760"}},"subtitle":["Case report and literature review"],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":15,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021760","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]}}}